- Home
- GOVX vs INKT Comparison
GOVX vs INKT Comparison
Compare GOVX & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- INKT
- Stock Information
- Founded
- GOVX 2001
- INKT 2017
- Country
- GOVX United States
- INKT United States
- Employees
- GOVX N/A
- INKT N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- INKT Medicinal Chemicals and Botanical Products
- Sector
- GOVX Health Care
- INKT Health Care
- Exchange
- GOVX Nasdaq
- INKT Nasdaq
- Market Cap
- GOVX 23.8M
- INKT 28.5M
- IPO Year
- GOVX N/A
- INKT 2021
- Fundamental
- Price
- GOVX $2.26
- INKT $0.46
- Analyst Decision
- GOVX Strong Buy
- INKT Strong Buy
- Analyst Count
- GOVX 5
- INKT 2
- Target Price
- GOVX $14.20
- INKT $6.50
- AVG Volume (30 Days)
- GOVX 715.7K
- INKT 43.7K
- Earning Date
- GOVX 11-12-2024
- INKT 11-14-2024
- Dividend Yield
- GOVX N/A
- INKT N/A
- EPS Growth
- GOVX N/A
- INKT N/A
- EPS
- GOVX N/A
- INKT N/A
- Revenue
- GOVX $3,090,161.00
- INKT N/A
- Revenue This Year
- GOVX N/A
- INKT N/A
- Revenue Next Year
- GOVX $150.51
- INKT N/A
- P/E Ratio
- GOVX N/A
- INKT N/A
- Revenue Growth
- GOVX N/A
- INKT N/A
- 52 Week Low
- GOVX $1.09
- INKT $0.46
- 52 Week High
- GOVX $11.18
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- GOVX 44.80
- INKT 15.27
- Support Level
- GOVX $2.17
- INKT $0.64
- Resistance Level
- GOVX $2.50
- INKT $0.67
- Average True Range (ATR)
- GOVX 0.17
- INKT 0.06
- MACD
- GOVX -0.04
- INKT -0.02
- Stochastic Oscillator
- GOVX 18.33
- INKT 0.00
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.